Research Chemicals, Peptides & SARMs (Unregulated)
HMTc Category 26 master node (Peptides, SARMs, and Research Chemicals). Promoted from the 2026-06-08 provisional scaffold under the v2.1 taxonomy reorganization (category-26-step0-lock). This category covers unregulated ingestible and injectable compounds sold outside the supplement framework; it is legally distinct from Category 16. The four rows (injectable peptide hormones, oral SARMs, injectable AAS, raw AAS/peptide powders) are routing destinations with no candidate values yet. This class introduces the parenteral pathway: an injected compound bypasses gut absorption, so derivation must apply the documented methodology variants (no regulatory anchor, so the min() cap term drops; a potentially tighter health-based term) before any value is published. Collagen and protein-peptide supplements route to Category 16; topical peptide serums to Category 13.
Triggering source: Lead Astray? The Hidden Contaminants in Australian Anabolic–Androgenic Steroid Market and Their Potential Health Impact
Literature scope
The literature corpus for this product class is currently thin. Sources route here as ingest proceeds; once enough sources accumulate, the synthesis pass will populate the Literature Evidence Summary, Source Evidence Inventory, and downstream sections per CLAUDE.md Part 6.
Sources
Auto-generated from source-page frontmatter. The “Used on this page for” column is populated by the orchestrator’s POPULATE-SOURCE-LEGEND action; pending entries appear as *[awaiting synthesis]*.
| # | Citation | Year | Type | Used on this page for |
|---|---|---|---|---|
| 1 | Craven et al. 2025. Lead Astray? The Hidden Contaminants in Australian Anabolic–Androgenic Steroid Market and Their Potential Health Impact, Drug and Alcohol Review | 2025 | Peer-reviewed | AU Pb, Cd, tAs, Al, Cr, Ni occurrence in 28 illicit anabolic–androgenic steroid (AAS) products anonymously donated by people who use AAS in Australia (reportedly purchased 2022–2024):… (n=28) |
| 2 | Janvier et al. 2018. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market, Talanta | 2018 | Peer-reviewed | BE iAs, tAs, Pb, Cd occurrence in 27 falsified/unregulated polypeptide drug preparations acquired as ‘research chemicals’ from three suspected illegal internet pharmacies and delivered to… (n=27) |
Page history
The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.
| Commit | Date | Description |
|---|---|---|
| e038a80 | 2026-07-02 | feat(index): category SECTION pages + lean directory (Examine hierarchy) |